Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGA4 | P13612 | 14/20 | 0.49 |
| ▸ | ITGB7 | P26010 | 12/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ITGB1 | P05556 | 5/20 | 0.49 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.46 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KCNQ1 | P51787 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3314005 | 0.83 | ITGA4 (0.65) | ITGA4ITGB7ITGB1 | |
| SCHEMBL3317078 | 0.82 | ITGA4 (0.57) | ITGA4ITGB7ITGB1 | |
| SCHEMBL5175652 | 0.79 | L3MBTL1 (0.42) | ITGA4ITGB7ITGB1HCRTR1HCRTR2 | |
| SCHEMBL6141659 | 0.78 | ITGA4 (0.54) | ITGA4ITGB7ITGB1 | |
| SCHEMBL4625291 | 0.77 | ITGB1 (0.39) | ITGA4ITGB7TDP1ITGB1LMNA | |
| SCHEMBL3859283 | 0.76 | ITGA4 (0.75) | ITGA4ITGB7ITGB1 | |
| SCHEMBL4624059 | 0.73 | ITGA4 (0.50) | ITGA4ITGB7TDP1ITGB1LMNA | |
| SCHEMBL13570517 | 0.69 | FKBP1A (0.69) | TDP1HCRTR1HCRTR2RAB9A | |
| SCHEMBL13570871 | 0.69 | TDP1 (0.69) | TDP1RAB9ASMN1; SMN2 | |
| SCHEMBL6140371 | 0.69 | ITGA4 (0.53) | ITGA4ITGB7ITGB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1501801-B1 | 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES | UCB PHARMA SA (BE) | 2008-01-23 | — | — | EP | claimed |